These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3079434)
1. Inappropriate HLA class II expression on epithelial cells: new insight in the pathogenesis of distinctive autoimmunity. Bottazzo GF; Londei M; Bosi E; Mirakian R; Belfiore A; De Berardinis PG; Todd I; Pujol-Borrell R; Feldmann M Ann Ital Med Int; 1986; 1 Suppl 1():20-3. PubMed ID: 3079434 [No Abstract] [Full Text] [Related]
2. HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro. Todd I; Pujol-Borrell R; Abdul-Karim BA; Hammond LJ; Feldmann M; Bottazzo GF Clin Exp Immunol; 1987 Sep; 69(3):532-42. PubMed ID: 3117460 [TBL] [Abstract][Full Text] [Related]
3. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts. Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281 [TBL] [Abstract][Full Text] [Related]
5. Modulation of MHC class II expression in human cells by dexamethasone. Schwiebert LM; Schleimer RP; Radka SF; Ono SJ Cell Immunol; 1995 Oct; 165(1):12-9. PubMed ID: 7671315 [TBL] [Abstract][Full Text] [Related]
6. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Liversidge JM; Sewell HF; Forrester JV Clin Exp Immunol; 1988 Sep; 73(3):489-94. PubMed ID: 3145163 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules. De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708 [TBL] [Abstract][Full Text] [Related]
8. HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Pallone F; Fais S; Capobianchi MR Clin Exp Immunol; 1988 Oct; 74(1):75-9. PubMed ID: 3146453 [TBL] [Abstract][Full Text] [Related]
9. HLA DR, DP, DQ induction in human islet beta cells by the cytokine combination IFN-gamma + TNF-alpha. Soldevila G; Doshi M; James R; Lake SP; Sutton R; Gray D; Bottazzo GF; Pujol-Borrell R Autoimmunity; 1990; 6(4):307-17. PubMed ID: 2129492 [TBL] [Abstract][Full Text] [Related]
10. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. Muczynski KA; Anderson SK; Pious D J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276 [TBL] [Abstract][Full Text] [Related]
11. The distribution and differential expression of MHC class II antigens (HLA-DR, DP, and DQ) in human fetal adrenal, pancreas, thyroid, and gut. Oliver AM; Sewell HF; Abramovich DR; Thomson AW Transplant Proc; 1989 Feb; 21(1 Pt 1):651-2. PubMed ID: 2495628 [No Abstract] [Full Text] [Related]
12. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon. Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737 [TBL] [Abstract][Full Text] [Related]
13. HLA-D/DR expression on epithelial cells: the finger on the trigger? Todd I; Londei M; Pujol-Borrell R; Mirakian R; Feldmann M; Bottazzo GF Ann N Y Acad Sci; 1986; 475():241-50. PubMed ID: 3098153 [TBL] [Abstract][Full Text] [Related]
15. Keratinocyte expression of class II MHC antigens in long-lasting allergic patch test reactions. Todd DJ; Handley J; Walsh M; Dolan O; Burrows D Contact Dermatitis; 1992 Jan; 26(1):22-6. PubMed ID: 1600734 [TBL] [Abstract][Full Text] [Related]
16. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes. Pujol-Borrell R; Todd I; Londei M; Foulis A; Feldmann M; Bottazzo GF Mol Biol Med; 1986 Apr; 3(2):159-65. PubMed ID: 3090400 [TBL] [Abstract][Full Text] [Related]
17. Peptides presented in vivo by HLA-DR in thyroid autoimmunity. Muixí L; Alvarez I; Jaraquemada D Adv Immunol; 2008; 99():165-209. PubMed ID: 19117535 [TBL] [Abstract][Full Text] [Related]
18. Epithelial expression of HLA class II molecules: a new pathogenic factor in organ-specific autoimmunity. Bottazzo GF; Todd I; Belfiore A; Pujol-Borrell R Acta Med Scand Suppl; 1987; 715(Suppl 715):79-83. PubMed ID: 3296676 [No Abstract] [Full Text] [Related]
19. Class II antigens in Hashimoto thyroiditis. I. Synthesis and expression of HLA-DR and HLA-DQ by thyroid epithelial cells. Möst J; Knapp W; Wick G Clin Immunol Immunopathol; 1986 Nov; 41(2):165-74. PubMed ID: 3533331 [TBL] [Abstract][Full Text] [Related]
20. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody. Lloyd RV; Johnson TL; Blaivas M; Sisson JC; Wilson BS Am J Pathol; 1985 Jul; 120(1):106-11. PubMed ID: 3893150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]